Key Takeaways Real-world results with weight-loss drugs aren’t as impressive as those in clinical trialsClinic patients ...

Scientists know the stomach talks to the brain, but two new studies from Rutgers Health researchers suggest the conversation ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...

CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse ...

Patients who remained on treatment, especially at higher doses or on tirzepatide, were more likely to achieve clinically meaningful weight loss and improved glycemic control.

Lembas is a new b2b ingredient business that makes a peptide powder that targets the GLP-1 hormone for weight loss ...

This is not just about managing risk, it's also the biggest opportunity in a generation, says Henry Dimbleby, author of the ...

Coming off a successful initial public offering, Omada Health President Wei-Li Shao said the company is focused on turning a ...

GLP-1 meds may help — or harm — those with bipolar disorder. Read firsthand accounts of mood changes, weight loss, and side ...

CLARE Butler struggled with her weight for most of her adult life. As an emotional eater, food was her go-to whenever she ...

Drugs that promise rapid and effortless weight loss once seemed like the stuff of fairytales. Now, even if we’re not “on the ...